Biological E. Limited

Grantee Website Telangana, India
Purpose
to respond to the COVID-19 pandemic by developing a SARS-CoV-2 vaccine evaluated through Phase 1 clinical testing
Division
Global Health
Date
APRIL 2020
Region Served
GLOBAL
Committed Amount
$4,019,427
Grant Topic
Vaccine Development
Duration (Months)
21
Grantee Location
Telangana, India

More about our work

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.